Take the Assessment Total monthly cost (35%): The single most important factor for uninsured patients
4 Likes Neo February 9, 2024, 12:59am #457 Been reading up on Acarbose on the forum and did not really see this mechanism of potential longevity via Acarbose mentioned or discussed, so thought Id add it to the discussion
FOUNDAYO is a small-molecule, non-peptide GLP-1 receptor agonist
Side effects can be troublesome, but treating obesity is one of the best things you can ever do for your health, and will lower your risk of developing many other health conditions, including heart disease and some cancers
In those people taking GLP-1 drugs, there was reduced risk of substance use and psychotic disorders, seizures, Alzheimers disease and dementia, cardiometabolic disorders and several respiratory conditions